Stimulator, Electrical, Implanted, For Parkinsonian Symptoms
NHL is the FDA product code for Stimulator, Electrical, Implanted, For Parkinsonian Symptoms, a class III device type. FDA's definition for this code reads: "Bilateral stimulation of the internal globus pallidus (GPi) or the subthalamic nucleus (STN) using Medtronic Activa Parkinson's Control Therapy is indicated for adjunctive therapy in reducing some of the symptoms of advanced, levodopa-responsive Parkinsons disease that are not adequately controlled with medication". As of , FDA records hold no 510(k) clearances under this code and 4 recalls.
Classification record
- Product code
- NHL
- Device name
- Stimulator, Electrical, Implanted, For Parkinsonian Symptoms
- FDA definition
- Bilateral stimulation of the internal globus pallidus (GPi) or the subthalamic nucleus (STN) using Medtronic Activa Parkinson's Control Therapy is indicated for adjunctive therapy in reducing some of the symptoms of advanced, levodopa-responsive Parkinsons disease that are not adequately controlled with medication.
- Device class
- Class III
- Review panel
- Unknown
- Submission type
- PMA
- Implant
- Yes
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 0
- Ingested recalls
- 4
Companies listing this code with FDA
Companies whose registered establishments list this code- Abbott Medical
- Armor Plast Ltd
- AUSA Medical Device Pvt Ltd
- Benchmark Electronics, Inc.
- Boston Scientific Corporation
- Boston Scientific Neuromodulation Corporation
- CENTERPIECE S. de R.L de C.V (sterilization site)
- Eca Medical Instruments
- Eptam Precision Molding MA (a Division of Eptam Precision)
- Isomedix Operations Inc
- Jabil Circuit (Shanghai) Ltd.
- Medtronic Distribution Center
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
